Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Join Brooke in the Don’t Talk-A-Thon
“ALS research is the only hope we have, so anything we can do to raise money for ALS research is crucial. It directly impacts how
May 18, 2023
No Comments
